Share

Latest Documents


  • 23-March-2018

    English

    Gene editing in an international context: Scientific, economic and social issues across sectors

    There is broad agreement that gene editing techniques go beyond incremental advances of past biotechnologies, but harnessing the potential will require meeting significant policy challenges in arenas of governance, ethics, and public engagement. This report summarises the discussions of a group of international experts and policymakers.

    Related Documents
  • 18-January-2018

    English

    Revised proposal for the revision of the statistical definitions of biotechnology and nanotechnology

    This document revises the OECD's statistical definition of biotechnology, which had last been reviewed in 2008, and proposes the adoption of a statistical definition of nanotechnology in the same format.

  • 30-November-2017

    English

    Neurotechnology and society: Strengthening responsible innovation in brain science

    This report identifies, and seeks to address, key challenges for the responsible development of neurotechnology. In particular, it analyses frameworks and mechanisms for integrating social concerns in the early development of technology, and discusses best practices for research funders across the public and private sector.

    Related Documents
  • 9-November-2017

    English

    Key nanotechnology indicators

    Indicators include nanotech firms, nanotech R&D, public sector R&D expenditure and nanotechnology patents.

    Related Documents
  • 9-November-2017

    English

    Key biotechnology indicators

    Statistics on biotechnology firms, biotechnology R&D (including public sector expenditures), biotech applications and patents.

  • 26-September-2017

    English

    Marine biotechnology: Definitions, infrastructures and directions for innovation

    Several countries have been setting up strategic roadmaps to support marine biotechnologies that could drive innovation and help address the global sustainability goals of food, energy, and health. This report identifies and begins to address challenges facing cooperation on marine biotechnology across countries.

  • 22-September-2017

    English

    The microbiome, diet and health: Towards a science and innovation agenda

    There is now strong evidence that microbiomes play an important role in human health, as there are clear linkages to many major non-communicable diseases. This report assesses the key policy challenges for innovation in the microbiome. It argues that if such a promising scientific field is to lead to innovative applications, policies on science and innovation must be improved in five areas.

    Related Documents
  • 9-September-2016

    English

    Global Action to Drive Innovation in Alzheimer's Disease and Other Dementias: Connecting Research, Regulation and Access

    A December 2015 workshop in Lausanne reviewed the policy and stakeholder actions needed to accelerate biomedical research and health innovation for Alzheimer’s disease and other dementias. There is consensus across all stakeholders to move from global agenda setting in Alzheimer’s disease to action oriented programmes and implementation.

  • 22-April-2015

    English

    Enhancing Translational Research and Clinical Development for Alzheimer's Disease and other Dementias

    Accelerating innovation for Alzheimer’s disease and other dementias is a key challenge. An OECD workshop in November 2014 provided an international forum for all stakeholders to drive forward a change in the global paradigm in biomedical research and health innovation for Alzheimer’s disease and other dementias.

  • 9-April-2015

    English

    Public-private Partnerships in Biomedical Research and Health Innovation for Alzheimer's Disease and other Dementias

    This report looks at the roles and options of stakeholders (governments, regulatory agencies, academia, small and mid-size biotech companies, the pharmaceutical industry, and patient organisations) in public-private partnerships for product development in Alzheimer’s disease and other dementias.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 > >>